LEVY Health, the company developing a CE-compliant software that helps women “decode their fertility”, has now raised €2.5M led by Atlantic Labs with participation from Calm/Storm Ventures as well as several notable angel investors including Ava Founder Lea von Bidder and Oviavo’s Jenny Saft.
LEVY’s platform offers precision infertility diagnostics based on a woman’s personal medical history and results from blood tests, that are then reviewed by reproductive physicians. Based on the results, women are then given personalized therapy recommendations.
In an interview with TechFundingNews Caroline Mitterdorfer, LEVY Co-founder & CEO shared: “We are proud that we can now help women who want to have children both decode their fertility and show them how to boost their chances of conceiving with the LEVY Fertility Code. Thank you to all our new and old partners for their support and for joining us on our mission to fight for better women’s healthcare.”